年龄调节肥胖对危重症COVID-19患者死亡风险的影响:一项全国性观察性队列研究
该研究为全国性观察性队列,纳入国家重症监护评估登记库中15,701例危重症COVID-19患者,其中男性10,768例(68.6%),中位年龄64岁(四分位距55-71岁),<45岁者1,402例(8.9%)。在校正年龄、性别、急性生理与慢性健康评分IV、机械通气及血管活性药物使用后,全样本中BMI≥30 kg/m²不影响住院死亡率(校正OR=0.98;95%CI 0.90-1.06;p=0.62)。<45岁患者中BMI≥30 kg/m²与更低住院死亡率相关(校正OR=0.59;95%CI 0.36-0.96;p=0.03),而≥45岁患者中未见此关联。作者认为较高BMI可能与<45岁患者更低死亡率相关,符合所谓「肥胖悖论」,需进一步研究。
要点
- 全样本校正后BMI≥30 kg/m²不影响危重症COVID-19住院死亡率:校正OR=0.98;95%CI 0.90-1.06;p=0.62。
- <45岁危重症COVID-19患者中BMI≥30 kg/m²与更低住院死亡率相关:校正OR=0.59;95%CI 0.36-0.96;p=0.03。
- 全国性登记库共15,701例,男性10,768例(68.6%),中位年龄64岁(55-71岁),<45岁1,402例(8.9%)。
- 作者认为较高BMI可能与<45岁患者更低死亡率相关,符合「肥胖悖论」,需进一步研究。
适用人群与场景
- 国家重症监护评估登记库中登记的危重症COVID-19患者,共15,701例,男性10,768例(68.6%),中位年龄64岁(四分位距55-71岁),<45岁者1,402例(8.9%)。
- 全国性登记库分析,设置于重症监护场景。
研究设计与关键结果
- 研究类型:观察性队列研究,全国性登记库分析,纳入15,701例危重症COVID-19患者。
- 全样本校正年龄、性别、急性生理与慢性健康评分IV、机械通气及血管活性药物使用后,BMI≥30 kg/m²不影响住院死亡率:校正OR=0.98;95%CI 0.90-1.06;p=0.62。
- <45岁患者中BMI≥30 kg/m²与更低住院死亡率相关:校正OR=0.59;95%CI 0.36-0.96;p=0.03;≥45岁患者中未见此关联。
- 作者结论:较高BMI可能与<45岁患者更低死亡率相关,符合其他危重症人群广泛年龄范围中建立的「肥胖悖论」;需进一步研究以理解年轻危重症COVID-19患者中的这一有利关联。
证据类型、等级与局限
- 证据类型:观察性队列研究(全国性登记库分析)。
- 局限:原文未报告局限性;作者在结论中提出需进一步研究以理解年轻危重症COVID-19患者中这一有利关联。
对床旁实践的改变
- 作者认为,较高BMI可能与<45岁危重症COVID-19患者更低死亡率相关,符合「肥胖悖论」,需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: A high body mass index (BMI) is associated with an unfavorable disease course in COVID-19, but not among those who require admission to the ICU. This has not been examined across different age groups. We examined whether age modifies the association between BMI and mortality among critically ill COVID-19 patients.
DESIGN: An observational cohort study.
SETTING: A nationwide registry analysis of critically ill patients with COVID-19 registered in the National Intensive Care Evaluation registry.
PATIENTS: We included 15,701 critically ill patients with COVID-19 (10,768 males [68.6%] with median [interquartile range] age 64 yr [55-71 yr]), of whom 1,402 (8.9%) patients were less than 45 years.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: In the total sample and after adjustment for age, gender, Acute Physiology and Chronic Health Evaluation IV, mechanical ventilation, and use of vasoactive drugs, we found that a BMI greater than or equal to 30 kg/m 2 does not affect hospital mortality (adjusted odds ratio [OR adj ] = 0.98; 95% CI, 0.90-1.06; p = 0.62). For patients less than 45 years old, but not for those greater than or equal to 45 years old, a BMI greater than or equal to 30 kg/m 2 was associated with a lower hospital mortality (OR adj = 0.59; 95% CI, 0.36-0.96; p = 0.03).
CONCLUSIONS: A higher BMI may be favorably associated with a lower mortality among those less than 45 years old. This is in line with the so-called "obesity paradox" that was established for other groups of critically ill patients in broad age ranges. Further research is needed to understand this favorable association in young critically ill patients with COVID-19.
参考来源
- den Uil CA, Termorshuizen F, Rietdijk WJR, et al. Age Moderates the Effect of Obesity on Mortality Risk in Critically Ill Patients With COVID-19: A Nationwide Observational Cohort Study. Crit Care Med. 2023. PMID: 36762902. doi:10.1097/CCM.0000000000005788
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。